Despite this, activin's signal transduction components are down-regulated in high-grade breast cancer at protein level, as well as activin βB subunit, demonstrating that even though activin A is abundantly available in breast carcinoma, its transduction pathway is decreased [4]. This evidence concerns the gene INHBE and breast cancer.